Actinium Pharmaceuticals, Inc.
ATNM
$1.52
-$0.03-1.94%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.02% | 21.66% | 18.40% | 8.02% | -19.33% |
| Total Depreciation and Amortization | -2.91% | 2.66% | 7.18% | 4.01% | 10.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 202.53% | 37.74% | 28.81% | 16.66% | 25.54% |
| Change in Net Operating Assets | -176.30% | 70.40% | 113.25% | 652.20% | -94.82% |
| Cash from Operations | 16.05% | 30.13% | 26.90% | 19.55% | -5,978.53% |
| Capital Expenditure | 100.00% | 92.81% | 93.49% | 80.66% | 79.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 92.81% | 93.49% | 80.66% | 79.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -80.00% | -125.00% | -100.00% | -16.67% | 82.14% |
| Issuance of Common Stock | -49.57% | 97.20% | 64.33% | 66.44% | 20.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.59% | 97.18% | 64.32% | 66.46% | 20.78% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.51% | 88.47% | 85.26% | 79.20% | -147.57% |